Rare cancer study aims to unlock secrets of adrenal tumors
NCT ID NCT07335679
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the medical records of 60 adults treated for adrenal cortex carcinoma at a French hospital. Researchers want to learn more about the disease's features and how long patients live after treatment. The goal is to better understand this rare cancer and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL CORTICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom mRNA vaccine takes on rare endocrine cancers
- New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
- Immunotherapy drug aims to keep adrenocortical cancer at bay
- New hope for kids with rare cancers: drug targets tumor growth
- Immunotherapy duo takes on rare tumors
- Michigan study tests ways to boost genetic testing in cancer patients